Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-002245
Filing Date
2020-01-28
Accepted
2020-01-28 19:24:09
Documents
2
Period of Report
2020-01-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2245
2 EX-24 DOCUMENT attachment1.htm EX-24 4611
  Complete submission text file 0000899243-20-002245.txt   8321
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O LANTHEUS HOLDINGS, INC. 331 NORTH BILLERICA MA 01862
Business Address
Blanchfield Paul (Reporting) CIK: 0001801395 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36569 | Film No.: 20555961